그는 제약사들이 올해 초 10월 말까지 4천만 회분의 백신 물량 확보가 가능하다고 했던 말은 잘못된 것이었다고 지적했다.
He pointed out that it was wrong to say that pharmaceutical companies could secure 40 million doses of vaccine by the end of October earlier this year.